Genialis, Inc.
BOSTON, MA · CIK 0001948756 · Biotech · Private
Software platform for analyzing genomic and clinical data to guide precision oncology drug development
genialis.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $12M
- 2 Form D · Dec 2025
- 9 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 9
- 0 granted · 9 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $11,423,253 | |
| Private capital raised | Form D · SEC | $700,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2482 | DMC Limited | — | — |
| 2483 | Curie Co. Inc. | — | $13M |
| 2484 | Incannex Healthcare Inc. | — | $12M |
| 2485 | Genialis, Inc. | — | $12M |
| 2486 | Borealis Biosciences | — | — |
| 2487 | PANOME BIO INC | — | $12M |
| 2488 | ANAVEX LIFE SCIENCES CORP. | — | $11M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Hamzeh Abdul-HadiDirector
- Luka AusecExecutive Officer
- Nadine GeiserDirector
- Tjasa KutinExecutive Officer
- Ita LuDirector
- Krista McKerracherDirector
- Cedric OdjeDirector
- Rafael RosengartenDirector · Executive Officer
- Miha StajdoharDirector · Executive Officer
- Elia StupkaDirector
- Drew VolpeDirector
Patents
- System Of Preprocessors To Harmonize Disparate 'omics Datasets By Addressing Bias And/or Batch Effectsapplication
- Evaluating The Robustness And Transferability Of Predictive Signatures Across Molecular Biomarker Datasetsapplication
- Prediction Of Tumor Response And Clinical Benefit From Kras Therapeutic Agentsapplication
- System Of Preprocessors To Harmonize Disparate 'omics Datasets By Addressing Bias And/or Batch Effectsapplication
- System Of Preprocessors To Harmonize Disparate 'omics Datasets By Addressing Bias And/or Batch Effectsapplication
- Evaluating The Robustness And Transferability Of Predictive Gene Signatures Across Genomic Datasetsapplication
- Prediction Of Tumor Response And Clinical Benefit From Kras Therapeutic Agentsapplication
- Evaluating The Robustness And Transferability Of Predictive Gene Signatures Across Genomic Datasetsapplication
- Prediction Of Tumor Response And Clinical Benefit From Kras Therapeutic Agentsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.